CN Bio

CN Bio’s mission is to transform drug discovery through the development of disruptive single and multi-organ microphysiological systems (MPS), otherwise known as organ-on-a-chip, that optimise the accuracy and productivity of bringing new medicines to market. By supporting more efficient drug discovery, before having to go to advanced and expensive animal or human clinical trials, CN Bio’s MPS can provide significant savings in cost and time.

This short video will introduce you to CN Bio and what differentiates us as a company. It details:

1) our mission to help improve the accuracy and efficiency of drug discovery by providing researchers with the ability to generate predictive human-relevant information. 

2) use of advanced single and multi-organ in vitro models, cultured using CN Bio's PhysioMimix™ OOC, to facilitate faster, cheaper and more insightful decisions regarding compound progression into the clinic versus traditional techniques alone.

3) the benefits of an organ-on-a-chip approach to drug metabolism and toxicology applications such as DILI, Human ADME, metabolite driven toxicity, on and off-target effects 

4) how to access this technology in your own lab, or through our in house testing services

Predicting the future: humanized drug evaluation testing using organ-on-a-chip technology

Discover the benefits of CN Bio's in vitro organ-on-a-chip (OOC) approach to drug metabolism and toxicology applications.

In just 60 seconds, we will explain how the PhysioMimix™ OOC from CN Bio, provides researchers within the pharmaceutical industry with human-relevant and predictive information through the use of advanced single and multi-organ in vitro models and assays.

The benefits of human-relevant in vitro drug metabolism and toxicology applications from CN Bio in 60 seconds

Despite the complex physiologically relevant 3D biology that it recreates in vitro, our PhysioMimix™ OOC Microphysiological System is rather simple to adopt, helping you transition from 2D into 3D cell culture with ease.<br/><br/>Through its ability to recreate human physiology in the lab, the PhysioMimix™ OOC can predict human responses to new therapeutic drug candidates. By supplementing data generated from entrenched 2D cell culture and animal studies, this system supports confident decision making across many drug discovery stages from target discovery right through to development. <br/>

PhysioMimix™ OOC Lab Benchtop Ready Microphysiological System

In this episode, we speak with Tomasz Kostrzewski, Director of Biology at CN Bio about how drugs are developed, including the challenges faced when designing and developing a drug, how drug discovery has evolved, and what trends we can expect to see in the future. This series is kindly brought to you by CN Bio, click here to find out more: https://bit.ly/3bn9gHF

TSE Explores Drug Discovery – How are drugs developed? S05E01

LabTube Meets Vaishnavi Manoharan, CN-BIO at SLAS 2020, San Diego, USA

CN Bio

Home

Videos

Playlists

About

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.